RhumbLine Advisers
PRCT icon

RhumbLine Advisers’s Procept Biorobotics PRCT Stock Holding History

RhumbLine Advisers’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.6M Buy
71,074
+5,547
+8% +$139K ﹤0.01% 2066
2026
Q1 		$1.64M Buy
65,527
+73
+0.1% +$2.06K ﹤0.01% 1965
2025
Q4 		$2.06M Sell
65,454
-10,021
-13% -$332K ﹤0.01% 1868
2025
Q3 		$2.69M Sell
75,475
-1,909
-2% -$87.2K ﹤0.01% 1745
2025
Q2 		$4.46M Buy
77,384
+13,011
+20% +$736K ﹤0.01% 1472
2025
Q1 		$3.75M Buy
64,373
+3,077
+5% +$210K ﹤0.01% 1500
2024
Q4 		$4.94M Buy
61,296
+3,242
+6% +$277K ﹤0.01% 1428
2024
Q3 		$4.65M Sell
58,054
-3,818
-6% -$271K ﹤0.01% 1468
2024
Q2 		$3.78M Buy
61,872
+5,793
+10% +$345K ﹤0.01% 1544
2024
Q1 		$2.77M Buy
56,079
+1,541
+3% +$73.3K ﹤0.01% 1740
2023
Q4 		$2.29M Buy
54,538
+5,023
+10% +$171K ﹤0.01% 1836
2023
Q3 		$1.62M Buy
49,515
+1,971
+4% +$67.2K ﹤0.01% 1959
2023
Q2 		$1.68M Buy
47,544
+12,957
+37% +$428K ﹤0.01% 2004
2023
Q1 		$982K Buy
34,587
+795
+2% +$28K ﹤0.01% 2126
2022
Q4 		$1.4M Buy
33,792
+1,308
+4% +$56.2K ﹤0.01% 1970
2022
Q3 		$1.35M Buy
32,484
+2,624
+9% +$105K ﹤0.01% 1982
2022
Q2 		$976K Buy
29,860
+22,634
+313% +$823K ﹤0.01% 2153
2022
Q1 		$253K Buy
+7,226
New +$174K ﹤0.01% 2691

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

RhumbLine Advisers's PRCT Position: Q2 2026 in Review

RhumbLine Advisers increased its Procept Biorobotics (PRCT) stake by 8.5% in Q2 2026, buying an estimated $139K and bringing the position to 71,074 shares worth $1.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2066.

RhumbLine Advisers first reported a position in PRCT in Q1 2022 and has held it in 18 quarters since. The position peaked at $4.94M in Q4 2024. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • RhumbLine Advisers held 71,074 shares of Procept Biorobotics worth $1.6M as of Q2 2026.
  • RhumbLine Advisers bought 5,547 Procept Biorobotics shares in Q2 2026, an estimated $139K.
  • Procept Biorobotics made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #2066 holding.
  • RhumbLine Advisers first reported a position in Procept Biorobotics in Q1 2022 and has held it in 18 quarters since.
  • RhumbLine Advisers's Procept Biorobotics position peaked at $4.94M in Q4 2024.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.